Literature DB >> 12933593

Prospective studies of diagnostic test accuracy when disease prevalence is low.

Nancy A Obuchowski1, Xiao-Hua Zhou.   

Abstract

Prospective studies of diagnostic test accuracy have important advantages over retrospective designs. Yet, when the disease being detected by the diagnostic test(s) has a low prevalence rate, a prospective design can require an enormous sample of patients. We consider two strategies to reduce the costs of prospective studies of binary diagnostic tests: stratification and two-phase sampling. Utilizing neither, one, or both of these strategies provides us with four study design options: (1) the conventional design involving a simple random sample (SRS) of patients from the clinical population; (2) a stratified design where patients from higher-prevalence subpopulations are more heavily sampled; (3) a simple two-phase design using a SRS in the first phase and selection for the second phase based on the test results from the first; and (4) a two-phase design with stratification in the first phase. We describe estimators for sensitivity and specificity and their variances for each design, along with sample size estimation. We offer some recommendations for choosing among the various designs. We illustrate the study designs with two examples.

Entities:  

Year:  2002        PMID: 12933593     DOI: 10.1093/biostatistics/3.4.477

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  20 in total

1.  Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.

Authors:  J Tamaki; M Iki; E Kadowaki; Y Sato; E Kajita; S Kagamimori; Y Kagawa; H Yoneshima
Journal:  Osteoporos Int       Date:  2011-01-29       Impact factor: 4.507

Review 2.  The validation of screening tests: meet the new screen same as the old screen?

Authors:  Blase Gambino
Journal:  J Gambl Stud       Date:  2012-12

3.  Effect of voxel size on detection of fenestration, dehiscence and furcation defects using cone-beam computed tomography.

Authors:  Masoumeh Eftekhar; Hanieh Kaviani; Nina Rouzmeh; Aitin Torabinia; Alireza Akbarzadeh Baghban
Journal:  Oral Radiol       Date:  2021-01-11       Impact factor: 1.852

4.  Setting criterion thresholds for estimating prevalence: what is being validated?

Authors:  Blase Gambino
Journal:  J Gambl Stud       Date:  2014-09

5.  A new method to address verification bias in studies of clinical screening tests: cervical cancer screening assays as an example.

Authors:  Xiaonan Xue; Mimi Y Kim; Philip E Castle; Howard D Strickler
Journal:  J Clin Epidemiol       Date:  2013-12-12       Impact factor: 6.437

6.  Development and Validation of an Algorithm to Identify Planned Readmissions From Claims Data.

Authors:  Leora I Horwitz; Jacqueline N Grady; Dorothy B Cohen; Zhenqiu Lin; Mark Volpe; Chi K Ngo; Andrew L Masica; Theodore Long; Jessica Wang; Megan Keenan; Julia Montague; Lisa G Suter; Joseph S Ross; Elizabeth E Drye; Harlan M Krumholz; Susannah M Bernheim
Journal:  J Hosp Med       Date:  2015-07-07       Impact factor: 2.960

7.  Multifactorial analysis of affinity-mass spectrometry data from serum protein samples: a strategy to distinguish patients with preeclampsia from matching control individuals.

Authors:  Ulrich Pecks; Franka Seidenspinner; Claudia Röwer; Toralf Reimer; Werner Rath; Michael O Glocker
Journal:  J Am Soc Mass Spectrom       Date:  2010-01-04       Impact factor: 3.109

8.  Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram.

Authors:  S K Sandhu; N D Nguyen; J R Center; N A Pocock; J A Eisman; T V Nguyen
Journal:  Osteoporos Int       Date:  2009-07-25       Impact factor: 4.507

9.  Repeated significance tests of linear combinations of sensitivity and specificity of a diagnostic biomarker.

Authors:  Mixia Wu; Yu Shu; Zhaohai Li; Aiyi Liu
Journal:  Stat Med       Date:  2016-03-07       Impact factor: 2.373

10.  Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies.

Authors:  Steven J Skates; Michael A Gillette; Joshua LaBaer; Steven A Carr; Leigh Anderson; Daniel C Liebler; David Ransohoff; Nader Rifai; Marina Kondratovich; Živana Težak; Elizabeth Mansfield; Ann L Oberg; Ian Wright; Grady Barnes; Mitchell Gail; Mehdi Mesri; Christopher R Kinsinger; Henry Rodriguez; Emily S Boja
Journal:  J Proteome Res       Date:  2013-10-28       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.